A mint, coffee or fruit flavor name cannot establish whether a guarana pouch contains an allergen. For a private-label order, request a current allergen statement for every ingredient code and a separate review of manufacturing cross-contact. Approve the finished label against the actual formula and destination market before printing cans.
GuaranaPouches.com supplier-side editorial guide. This article explains a document-review process; it does not declare our products or any supplier’s products allergen-free.
Start with ingredient codes, not flavor names
“Vanilla mint” describes the intended taste. It does not identify the flavor supplier, carrier system or formulation revision. Two materials sold under similar flavor names may have different supporting documents. Ask for the manufacturer’s ingredient code and use that code consistently in the approved formula, purchase order and allergen review.
Review the guarana extract as well as the flavor system. Obtain information for carriers, sweeteners and processing aids that are relevant to the finished product. The request should distinguish an intentionally used allergenic ingredient from possible unintended cross-contact. Those are separate questions and may require different evidence. A generic company declaration with no material codes or revision date should prompt a follow-up, especially when the supplier has changed a raw material since the last order.
Documents to match to the formula
- Ingredient specification with supplier code and revision.
- Allergen declaration identifying its market scope.
- Composition or sub-ingredient information needed for the label review.
- Cross-contact assessment for the production route.
- Change-notification agreement covering substitutions and site changes.
Use the destination market’s allergen framework
The FDA identifies nine major food allergens in the United States: milk, eggs, fish, Crustacean shellfish, tree nuts, peanuts, wheat, soybeans and sesame. Sesame requirements took effect on 1 January 2023. This list is a starting point for a U.S. food or dietary-supplement review, not a worldwide list of every substance capable of causing a reaction.
First confirm the legal classification and market access of the proposed guarana pouch. Then have the responsible regulatory reviewer apply the labeling requirements for that product and jurisdiction. FDA’s January 2025, fifth-edition allergen guidance addresses questions involving flavors and other ingredient-labeling situations. A supplier’s trade-secret flavor formula does not remove the need to provide the information required for a lawful label. Where commercial confidentiality is an issue, arrange a controlled disclosure to the responsible reviewer.
Separate formulation review from shared-equipment risk
A formula can omit a particular allergen while the production route still requires a cross-contact assessment. Ask the manufacturer which materials share receiving, storage, weighing and filling equipment with the proposed SKU. Request the reasoning behind its controls, including how a changeover is checked. An ingredient statement alone does not answer those operational questions.
The FDA describes cross-contact as inadvertent introduction of a major allergen and advises that precautionary statements should not substitute for good manufacturing practices. For the buyer, a useful follow-up is specific: “What evidence supports this statement for this SKU on this line?” Avoid treating “made in a facility” wording as either proof of contamination or proof that a product is safe for a person with an allergy. Consumer questions about a known allergy need a product-specific answer from the responsible business, not reassurance based on the flavor name.
Make formula changes trigger a new label check
A repeat order can require another review even when the can design is unchanged. A new flavor code, carrier supplier or manufacturing location should trigger a documented comparison against the approved version. Ask who can authorize the change and who decides whether the packaging text must change before production resumes.
For example, imagine a supplier proposes a replacement coffee flavor because the original is unavailable. The buyer should request the new material’s documents and review them before approving substitution. This is a purchasing scenario, not a report of an incident. Link the decision to the finished SKU and retain the superseded version. Our lot-traceability guide explains how ingredient and packaging versions connect to finished cans. The RFQ checklist provides a place to request change control at the start of the project.
A compact approval record
- Record the finished SKU and formula version.
- List the ingredient codes and the document revisions reviewed.
- Record the market and proposed label wording.
- Identify unresolved questions and who must answer them.
- Approve only the version supported by the completed review.
Frequently asked questions
Does “natural flavor” mean a guarana pouch is allergen-free?
No. The term does not establish an allergen status. Review the flavor’s documentation and the finished product’s applicable labeling requirements.
Does “vegan” prove that a pouch is free of all major allergens?
No. Vegan and allergen statements address different properties. Plant-derived ingredients can still require allergen review, and a vegan claim does not describe cross-contact controls.
Can an allergen test replace the supplier’s ingredient documents?
A test answers a defined analytical question for the samples and method used. It should support a risk-based review, not replace ingredient identification, supplier information and manufacturing controls.
References and scope
- FDA: Food Allergies.
- FDA: Questions and Answers Regarding Food Allergen Labeling, Edition 5.
- FDA: FAQs about the 2025 allergen guidance updates.
- Verifying vegan and sugar-free guarana pouch claims.
References checked 29 October 2026. The approval record is an editorial purchasing aid, not legal advice or an allergy-safety guarantee. Confirm requirements for the actual product and destination.